213 related articles for article (PubMed ID: 9613860)
1. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).
Smith AC; Dykens E; Greenberg F
Am J Med Genet; 1998 Mar; 81(2):186-91. PubMed ID: 9613860
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).
Niederhofer H
Psychiatr Danub; 2007 Sep; 19(3):189-92. PubMed ID: 17914318
[TBL] [Abstract][Full Text] [Related]
3. [Smith-Magenis syndrome: a report of two new cases and an approximation to their characteristic behavioural phenotype].
Blanco-Barca O; Gallego-Blanco M; Ruiz-Ponte C; Barros-Angueira F; Esquete-López C; Eirís-Puñal J; Castro-Gago M
Rev Neurol; 2004 Jun 1-15; 38(11):1038-42. PubMed ID: 15202082
[TBL] [Abstract][Full Text] [Related]
4. Mutations in RAI1 associated with Smith-Magenis syndrome.
Slager RE; Newton TL; Vlangos CN; Finucane B; Elsea SH
Nat Genet; 2003 Apr; 33(4):466-8. PubMed ID: 12652298
[TBL] [Abstract][Full Text] [Related]
5. Systemic growth hormone corrects sleep disturbance in Smith-Magenis syndrome.
Itoh M; Hayashi M; Hasegawa T; Shimohira M; Kohyama J
Brain Dev; 2004 Oct; 26(7):484-6. PubMed ID: 15351087
[TBL] [Abstract][Full Text] [Related]
6. Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2).
Smith AC; Dykens E; Greenberg F
Am J Med Genet; 1998 Mar; 81(2):179-85. PubMed ID: 9613859
[TBL] [Abstract][Full Text] [Related]
7. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome.
De Leersnyder H; De Blois MC; Claustrat B; Romana S; Albrecht U; Von Kleist-Retzow JC; Delobel B; Viot G; Lyonnet S; Vekemans M; Munnich A
J Pediatr; 2001 Jul; 139(1):111-6. PubMed ID: 11445803
[TBL] [Abstract][Full Text] [Related]
8. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2).
Greenberg F; Lewis RA; Potocki L; Glaze D; Parke J; Killian J; Murphy MA; Williamson D; Brown F; Dutton R; McCluggage C; Friedman E; Sulek M; Lupski JR
Am J Med Genet; 1996 Mar; 62(3):247-54. PubMed ID: 8882782
[TBL] [Abstract][Full Text] [Related]
9. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
[TBL] [Abstract][Full Text] [Related]
10. Mosaicism for del(17)(p11.2p11.2) underlying the Smith-Magenis syndrome.
Juyal RC; Kuwano A; Kondo I; Zara F; Baldini A; Patel PI
Am J Med Genet; 1996 Dec; 66(2):193-6. PubMed ID: 8958329
[TBL] [Abstract][Full Text] [Related]
11. Smith-Magenis syndrome.
Elsea SH; Girirajan S
Eur J Hum Genet; 2008 Apr; 16(4):412-21. PubMed ID: 18231123
[TBL] [Abstract][Full Text] [Related]
12. Genomic organisation of the approximately 1.5 Mb Smith-Magenis syndrome critical interval: transcription map, genomic contig, and candidate gene analysis.
Lucas RE; Vlangos CN; Das P; Patel PI; Elsea SH
Eur J Hum Genet; 2001 Dec; 9(12):892-902. PubMed ID: 11840190
[TBL] [Abstract][Full Text] [Related]
13. A physical map of the mouse shaker-2 region contains many of the genes commonly deleted in Smith-Magenis syndrome (del17p11.2p11.2).
Probst FJ; Chen KS; Zhao Q; Wang A; Friedman TB; Lupski JR; Camper SA
Genomics; 1999 Feb; 55(3):348-52. PubMed ID: 10049592
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic hand anomalies in Smith-Magenis syndrome: four new patients with del (17)(p11.2p11.2).
Kondo I; Matsuura S; Kuwajima K; Tokashiki M; Izumikawa Y; Naritomi K; Niikawa N; Kajii T
Am J Med Genet; 1991 Nov; 41(2):225-9. PubMed ID: 1785639
[TBL] [Abstract][Full Text] [Related]
15. Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome.
Yan J; Keener VW; Bi W; Walz K; Bradley A; Justice MJ; Lupski JR
Hum Mol Genet; 2004 Nov; 13(21):2613-24. PubMed ID: 15459175
[TBL] [Abstract][Full Text] [Related]
16. Constitutional interstitial deletion of 17(p11.2) (Smith-Magenis syndrome): a clinically recognizable microdeletion syndrome. Report of two cases and review of the literature.
Fischer H; Oswald HP; Duba HC; Doczy L; Simma B; Utermann G; Haas OA
Klin Padiatr; 1993; 205(3):162-6. PubMed ID: 8350589
[TBL] [Abstract][Full Text] [Related]
17. Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases.
Edelman EA; Girirajan S; Finucane B; Patel PI; Lupski JR; Smith AC; Elsea SH
Clin Genet; 2007 Jun; 71(6):540-50. PubMed ID: 17539903
[TBL] [Abstract][Full Text] [Related]
18. Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment.
De Leersnyder H
Trends Endocrinol Metab; 2006 Sep; 17(7):291-8. PubMed ID: 16890450
[TBL] [Abstract][Full Text] [Related]
19. Array comparative genomic hybridisation of 52 subjects with a Smith-Magenis-like phenotype: identification of dosage sensitive loci also associated with schizophrenia, autism, and developmental delay.
Williams SR; Girirajan S; Tegay D; Nowak N; Hatchwell E; Elsea SH
J Med Genet; 2010 Apr; 47(4):223-9. PubMed ID: 19752160
[TBL] [Abstract][Full Text] [Related]
20. Three young children with Smith-Magenis syndrome: their distinct, recognisable behavioural phenotype as the most important clinical symptoms.
Willekens D; De Cock P; Fryns JP
Genet Couns; 2000; 11(2):103-10. PubMed ID: 10893661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
